Key Takeaways
- • Benchmark Capital's stake in Cerebras Systems is valued at $5.5 billion following the company's IPO on May 14, 2026, representing a 12x return on its Series A co-lead investment in 2016, with the firm holding approximately 8.1% of outstanding shares post-offering.
- • Cerebras completed a blockbuster $5.55 billion IPO—the largest of 2026—with shares surging 68% on their Nasdaq debut, lifting the company's market capitalization close to $100 billion and creating two billionaires: CEO Andrew Feldman ($3.2 billion stake) and Chief Technology Officer Sean Lie ($1.7 billion stake).
- • Eclipse Fund conducted a share conversion and reorganization involving 2,153,875 Cerebras shares via pro-rata in-kind distributions among Eclipse funds and estate-planning vehicles, as disclosed in a Form 4 filing by director Susan Lior, reflecting portfolio restructuring among early investors.
- • Foundation Capital achieved a 76x return on its Cerebras investment, with a post-IPO stake valued at $4.8 billion, while OpenAI secured a unique $6 billion stake in the chipmaker post-IPO, and early investors including OpenAI co-founders Sam Altman ($27.8 million) and Greg Brockman ($24.2 million) realized substantial gains.
- • Cerebras' IPO marks a significant inflection point for venture capital returns after an extended dry spell, with the company's wafer-scale engine (WSE) technology—which manufactures entire AI chips on full semiconductor wafers rather than cutting individual chips from wafers—driving demand during the current AI infrastructure buildout cycle.
Summary
Cerebras Systems closed a landmark $5.55 billion initial public offering on May 14, 2026, marking the largest IPO of the year and delivering outsized returns to early-stage venture investors positioned in the artificial intelligence chip sector. The offering priced 34.5 million shares of Class A common stock, with shares opening well above the offer price and surging 68% on their Nasdaq debut. The dramatic first-day performance lifted Cerebras' market capitalization to approximately $100 billion, signaling strong institutional and retail appetite for AI infrastructure plays amid accelerating demand for semiconductor capacity.
Benchmark Capital and Foundation Capital—the two lead investors in Cerebras' Series A funding round in 2016—emerged as among the largest beneficiaries of the IPO. Benchmark's holdings are now valued at $5.5 billion, representing a 12x return on its original Series A investment, while the firm retains approximately 8.1% of outstanding shares post-offering. Foundation Capital achieved even greater returns, realizing a 76x multiple on its investment with a post-IPO stake valued at $4.8 billion. These returns underscore the venture capital industry's outsized exposure to foundational AI infrastructure, where early conviction investments have generated transformative multiples as the sector scaled.
Concurrent with the IPO closing, Eclipse Fund executed a significant share restructuring involving the reorganization of 2,153,875 Cerebras shares held for various Eclipse funds and estate-planning vehicles. Director Susan Lior disclosed the transaction through a Form 4 filing, revealing a pro-rata in-kind distribution mechanism that allowed the fund to convert Class B shares to Class A shares on a one-for-one basis, reflecting portfolio rebalancing and potential liquidity management strategies among early investors managing multi-generational wealth structures.
The Cerebras IPO also unlocked substantial value for a broader network of early-stage investors and strategic stakeholders. OpenAI negotiated unique terms granting the AI research company a $6 billion post-IPO stake in Cerebras, while OpenAI co-founders Sam Altman and Greg Brockman realized personal gains valued at $27.8 million and $24.2 million, respectively. Intel CEO Lip-Bu Tan, among other early investors, similarly realized significant markups on positions established during the company's private-capital phase.
The IPO comes after Cerebras withdrew a prior public offering filing seven months prior, choosing instead to raise private capital at a February 2026 valuation of $23.1 billion. The decision to re-enter public markets reflected CEO Andrew Feldman's assessment that the company had achieved operational maturity and sufficient scale to fund accelerating growth opportunities. Cerebras' proprietary wafer-scale engine (WSE) technology—which manufactures entire AI chips on complete semiconductor wafers rather than cutting individual chips from larger wafers—has differentiated the company amid robust demand for AI compute capacity, with competing chipmakers including Nvidia, Advanced Micro Devices, and Intel also seeing stock appreciation during the period.
Benchmark Capital and Foundation Capital—the two lead investors in Cerebras' Series A funding round in 2016—emerged as among the largest beneficiaries of the IPO. Benchmark's holdings are now valued at $5.5 billion, representing a 12x return on its original Series A investment, while the firm retains approximately 8.1% of outstanding shares post-offering. Foundation Capital achieved even greater returns, realizing a 76x multiple on its investment with a post-IPO stake valued at $4.8 billion. These returns underscore the venture capital industry's outsized exposure to foundational AI infrastructure, where early conviction investments have generated transformative multiples as the sector scaled.
Concurrent with the IPO closing, Eclipse Fund executed a significant share restructuring involving the reorganization of 2,153,875 Cerebras shares held for various Eclipse funds and estate-planning vehicles. Director Susan Lior disclosed the transaction through a Form 4 filing, revealing a pro-rata in-kind distribution mechanism that allowed the fund to convert Class B shares to Class A shares on a one-for-one basis, reflecting portfolio rebalancing and potential liquidity management strategies among early investors managing multi-generational wealth structures.
The Cerebras IPO also unlocked substantial value for a broader network of early-stage investors and strategic stakeholders. OpenAI negotiated unique terms granting the AI research company a $6 billion post-IPO stake in Cerebras, while OpenAI co-founders Sam Altman and Greg Brockman realized personal gains valued at $27.8 million and $24.2 million, respectively. Intel CEO Lip-Bu Tan, among other early investors, similarly realized significant markups on positions established during the company's private-capital phase.
The IPO comes after Cerebras withdrew a prior public offering filing seven months prior, choosing instead to raise private capital at a February 2026 valuation of $23.1 billion. The decision to re-enter public markets reflected CEO Andrew Feldman's assessment that the company had achieved operational maturity and sufficient scale to fund accelerating growth opportunities. Cerebras' proprietary wafer-scale engine (WSE) technology—which manufactures entire AI chips on complete semiconductor wafers rather than cutting individual chips from larger wafers—has differentiated the company amid robust demand for AI compute capacity, with competing chipmakers including Nvidia, Advanced Micro Devices, and Intel also seeing stock appreciation during the period.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.